J Allergy Clin Immunol 2017;140:89C100. [PMC free content] [PubMed] [Google Scholar] 9. production were assessed by ELISA. Outcomes: TFR cells

Continue readingJ Allergy Clin Immunol 2017;140:89C100

Anti-vimentin 84-1 was the principal antibody showing excellent specificity with regards to higher vimentin sign and lower crossreactivity, whereas V9

Continue readingAnti-vimentin 84-1 was the principal antibody showing excellent specificity with regards to higher vimentin sign and lower crossreactivity, whereas V9 gave an increased history with some immunoglobulins and clone 13 slightly